Kwality Pharmaceuticals Limited (BOM:539997)
India
· Delayed Price · Currency is INR 933.60
-16.60 (-1.75%)
At close: May 27, 2025
Kwality Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Kwality Pharmaceuticals had annual revenue of 3.70B INR with 20.52% growth. Kwality Pharmaceuticals had revenue of 1.16B in the quarter ending March 31, 2025, with 25.77% growth.
Revenue
3.70B
Revenue Growth
+20.52%
P/S Ratio
2.62
Revenue / Employee
4.59M
Employees
806
Market Cap
9.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.70B | 630.25M | 20.52% |
| Mar 31, 2024 | 3.07B | 561.42M | 22.36% |
| Mar 31, 2023 | 2.51B | -2.05B | -44.97% |
| Mar 31, 2022 | 4.56B | 1.93B | 73.42% |
| Mar 31, 2021 | 2.63B | 1.21B | 84.59% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,908.23B |
Kwality Pharmaceuticals News
- 4 months ago - Kwality Pharmaceuticals receives GMP approval from SFDA for its two manufacturing units in Amritsar - Business Upturn
- 5 months ago - Kwality Pharmaceuticals receives RCGM approval for pre-clinical studies of recombinant Erythropoietin - Business Upturn
- 5 months ago - Kwality Pharmaceuticals gets SAHPRA approval in South Africa for Tamoxifen 20mg tablet - Business Upturn